Biobeat Joins the Innovators Network at the American Heart Association Center for Health Technology and Innovation

American Heart Association consortium advances evidence-based health technology solutions

PETAH TIKVA, Israel, September 6, 2022 /PRNewswire/ — Biobeat, a company focused on remote patient monitoring platforms with AI analytics capabilities, has joined the American Heart Association’s Center for Health Innovation and Technology Innovators Network (the ). The Center focuses on building and fostering health technology relationships to develop innovative and scalable solutions.

The Innovators Network is a consortium that connects entrepreneurs, suppliers, researchers and taxpayers. Innovators’ Network members also have access to the Association’s digital guidelines, recommendations and best science as they develop digital technologies for healthcare. Members collaborate with the Center in a variety of ways, including creating models for clinical outcome studies, reducing the significant cost of developing those studies independently, helping to connect science with technology, and providing evidence that a digital platform improves health care outcomes a key concern. for providers and payers.

“The Center aims to promote the rapid, efficient and effective development of health technology,” said Robert A. HarringtonMD, FAHA, Past President of the American Heart Association (2019-2020), Volunteer Chair of the American Heart Association’s Health Tech Advisory Group for the Center and Arthur L. Bloomfield professor and chairman of the department of medicine, Stanford University. “Joining the Innovators Network gives members the opportunity to leverage the consortium and work to broaden and deepen their involvement in this field.”

“Biobeat is excited to join the Innovators Network,” said Arik Eisenkraft, MD, Vice President of Clinical and Regulatory at Biobeat. “It will provide unique access to research from the Association and others who innovate in this space, helping us achieve our goals of improving cardiovascular health and helping healthcare providers.”

See also  Niron Magnetics expands its management team with three key hires in technology and operations

About Biobeat

Biobeat joins the network of innovators and brings with it the Biobeat solution, the first cuffless blood pressure measurement tool to receive FDA clearance. Biobeat leverages health-related artificial intelligence and medical technology capabilities to collect and analyze patient data with a suite of optical sensor monitors and machine learning data platforms focused on actionable insights.

Wireless sensors that are placed on the wrist or chest allow remote monitoring of blood pressure and multiple physiological parameters of the patient. Patient health data is viewed by participating medical staff through Biobeat’s secure HIPAA and GDPR compliant cloud-based patient management platform. The platform includes an automated real-time early warning scoring system that incorporates advanced artificial intelligence algorithms to provide alerts on the patient’s health status. These capabilities are focused on helping medical teams deliver personalized patient care, such as adjusting therapy and early prevention of specific disease exacerbations. The company envisions that compliance with easy-to-use cuffless health sensor solutions will help healthcare professionals engage in timely and proactive care of patients with hypertension.

Additional Resources


Biobeat, located at Israel, is a company in the health technology space that creates solutions at the intersection of health AI, machine learning, and big data that combine to provide actionable insights for patient care. With wearable devices, an AI system for early detection of patient changes, and AI-supported decision-making tools, Biobeat focuses on developing tools and analytics to help healthcare professionals deliver personalized care effective for patients. Connect with us at,,


tamir raveh
[email protected]

See also  Chevron and MOECO will collaborate on advanced geothermal technology

SOURCE Biobeat

Leave a Comment